Paul Magreta

Paul has over 25 years of experience in bio-pharmaceutical operations in the United States and Europe, including leadership roles in business development, process engineering, process validation, and manufacturing science and technology (MSAT). He has led cross-functional global teams in facility design, start-up, and technology transfer for cGMP production of clinical and marketed biologics.

Paul has implemented lifecycle process validation for multiple commercial products, led the operational readiness for a new biologics facility, and regularly presented and defended process validation strategy during audits and FDA inspections. He has worked in the UK, Italy, Germany, and Spain; managed tech transfers between sites in these countries and has a working proficiency in Spanish.

Prior to consulting, Paul was responsible for developing a CDMO business within Grifols, was Head of Global Process Engineering at Novartis Vaccines and Diagnostics based in the UK, Head of Manufacturing Science and Technology at Genentech’s site in Porriño, Spain, and previously held positions of increasing responsibility within process development and manufacturing at Genentech in the US.

EDUCATION

University of Michigan
BSE, Chemical Engineering